Ayvakit (avapritinib tablets) — Cigna
Systemic mastocytosis
Initial criteria
- Patient age ≥ 18 years
- Platelet count ≥ 50 x 10^9/L (≥ 50,000/mcL)
- EITHER patient has indolent systemic mastocytosis OR patient has one of the following subtypes of advanced systemic mastocytosis: aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, or mast cell leukemia
Approval duration
1 year